PAR 7.69% 21.0¢ paradigm biopharmaceuticals limited..

Ann: PAR Appoints Business Development Consultant, page-127

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 602 Posts.
    lightbulb Created with Sketch. 140
    I'm not doubting every step they are taking. I'm trying to believe the company when they tell me that Plexus is responsible for deal origination for the rest of the world outside of China.

    So what you are saying is this is incorrect and deal interest originated to date in South America and MENA has somehow been originated by PAR itself? Because Plexus has no interest dealing in these markets.

    Now we have Scott Williams with ZERO experience in biotech deal negotiations bringing our regional deals home. Great, thanks for clarifying.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.